当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Targeted therapies: Precision medicine for ATC — BRAF and MEK inhibition shows promise
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2017-11-17 , DOI: 10.1038/nrclinonc.2017.181 David Killock
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2017-11-17 , DOI: 10.1038/nrclinonc.2017.181 David Killock
Targeted therapies: Precision medicine for ATC — BRAF and MEK inhibition shows promise
中文翻译:
靶向疗法:用于ATC的精密药物-抑制BRAF和MEK前景广阔
靶向疗法:用于ATC的精密药物-抑制BRAF和MEK前景广阔
更新日期:2017-11-19
Targeted therapies: Precision medicine for ATC — BRAF and MEK inhibition shows promise, Published online: 17 November 2017; doi:10.1038/nrclinonc.2017.181
中文翻译:
靶向疗法:用于ATC的精密药物-抑制BRAF和MEK前景广阔
靶向疗法:用于ATC的精密药物-抑制BRAF和MEK前景广阔
靶向治疗:用于ATC的精密药物-BRAF和MEK抑制显示出希望,在线发布:2017年11月17日;doi:10.1038 / nrclinonc.2017.181